Description

Patients with multiple sclerosis have an increased rate of autoimmune disorders such as autoimmune hepatitis. Immunomodultating therapy for multiple sclerosis (MS) may be followed by clinical hepatitis.

To read more or access our algorithms and calculators, please log in or register.